Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1999
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/31/1999CN1042728C Arylglycinamide derivatives and preparing process thereof
03/31/1999CN1042697C Method for preparing powder medicine for treating tympanitis
03/31/1999CN1042696C Film coating technique for strong VC Yinqiao tablets
03/30/1999US5889178 N-(2,2-diphenylethyl)-derivatives
03/30/1999US5889166 Recombinant neospora antigens and their uses
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889062 Ubiquinones
03/30/1999US5889060 Therapeutic use of(R)-Verapamil for treating angina
03/30/1999US5889058 Peptidyl derivatives
03/30/1999US5889057 Suckable solid
03/30/1999US5889056 Of nitric oxide synthase; hypotensive agent, antiinflammatory agents, antiarthritic agents
03/30/1999US5889055 Synergistic mixture; human and veterinary medicine
03/30/1999US5889054 Reducing the skin change associated with aging such as wrinkle, yellowing of skin, mottlling, leatheriness, loss of elasticity etc., comprising topically applying to the skin a wrinke or aging resistance beta-hydroxy acid
03/30/1999US5889053 Anticarcinogenic agents
03/30/1999US5889052 Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
03/30/1999US5889050 Immunomodulator
03/30/1999US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
03/30/1999US5889046 Method for preventing or alleviating cerebral apoplexy
03/30/1999US5889045 Benzopyran compounds
03/30/1999US5889043 Esterification
03/30/1999US5889042 Method of treating diseases and conditions with estrogen agonists and antagonists
03/30/1999US5889041 Method for treating an inflammatory pathological condition
03/30/1999US5889040 Anabolic protein composition with an amino acid profile close to human skeletal muscle tissue; acts synergistically with pyruvate to increase lean muscle mass; althetes, body builders
03/30/1999US5889039 Topical composition for fungal treatment
03/30/1999US5889038 Methods and products for treating diarrhea and scours: use of clotrimazole and related aromatic compounds
03/30/1999US5889037 Prevention, therapy tissue damage from lipid peroxidation
03/30/1999US5889036 Prophylactic or therapeutic drug for renal diseases
03/30/1999US5889035 1-(Arylthioalkyl, arylaminoalkyl or arylmethylenealkyl)-3-(heteroaryl) pyrrolidines and related compounds useful as antipsychotics and analgesics
03/30/1999US5889033 Famotidine a histamine h2-antagonist is used to amelilorate apathy-amotivation syndrome and second set of psychologiacal disorders treating agents are psychostimulants, muscarinic agents, acetyl-cholinesterase inhibitors and notropics
03/30/1999US5889030 Method for stabilizing pranoprofen and stable liquid preparation of pranaprofen
03/30/1999US5889029 Use of cotinine in treating psychiatric disorders
03/30/1999US5889028 Colonic delivery of nicotine to treat inflammatory bowel disease
03/30/1999US5889026 N-methyl-d-asparatate-receptor subtype selective blocker
03/30/1999US5889024 Substituted heterocycles
03/30/1999US5889022 Psychological disorders
03/30/1999US5889021 Active Compounds
03/30/1999US5889020 Treatment of normotensive glaucoma with angiotensin II antagonists
03/30/1999US5889018 Heterocyclic compounds, pharmaceutical compositions comprising them and process for the preparation thereof
03/30/1999US5889017 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
03/30/1999US5889015 Antiallergens, antihistamine
03/30/1999US5889014 Heterocyclic compounds for inhibiting phosphodiesterase IV
03/30/1999US5889013 Pyrimidine acyclonucleoside derivatives
03/30/1999US5889011 Substituted amino alkyl compounds
03/30/1999US5889008 Substituted 1-indolylpropyl-4-phenethylpiperazadine derivatives
03/30/1999US5889007 Chemisensitizing agents; cancer therapy drug resistance
03/30/1999US5889006 Muscarinic antagonists
03/30/1999US5889004 4-heteroaryl-1-piperazinealkylthiols and derivatives thereof and their therapeutic utility
03/30/1999US5889003 Phosphodiesterase inhibitor
03/30/1999US5889002 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
03/30/1999US5889000 Naphthofluorene compounds, intermediates, compositions and methods
03/30/1999US5888999 Using azacyclic and azabicyclic pyrazine compounds
03/30/1999US5888998 Increase effectiveness of b-lactam antibiotics
03/30/1999US5888996 Anticonvulsants
03/30/1999US5888994 Anticancer agnets; antitumor agents; glandular disorders
03/30/1999US5888993 Vanadium compounds in the treatment of elevated blood sugar levels
03/30/1999US5888991 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
03/30/1999US5888990 Phosphocholine drug derivatives
03/30/1999US5888988 Wound healing agent
03/30/1999US5888986 Method for treating the urinary bladder and associated structures using hyaluronic acid
03/30/1999US5888984 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
03/30/1999US5888977 Therapeutic uses of BPI protein products for human meningococcemia
03/30/1999US5888941 Carbozamides with antifungal activity
03/30/1999US5888820 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector
03/30/1999US5888791 Metabolites in culture
03/30/1999US5888771 Gene products as targets for the development of antibiotics.
03/30/1999US5888770 Spoiiie
03/30/1999US5888751 Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
03/30/1999US5888741 Computer-based design and screening of molecules using DNA interactions
03/30/1999US5888738 Design of drugs involving receptor-ligand-DNA interactions
03/30/1999US5888545 Spraying film-formers in combination with softener as aqueous solution or dispersion
03/30/1999US5888543 Administering two phase combination of progestin and estrogen at specified dosages and times during menstrual cycle
03/30/1999US5888542 Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route
03/30/1999US5888541 Increased calcium absorption ; osteoporosis therapy
03/30/1999US5888537 Liposomes comprised of phosphatidyl choline, cholesterol and phosphatidyl glycerol, having internal aqueous phase containing cationic vinca alkaloid and anion of low membrane permeability
03/30/1999US5888536 Alzheimer*s disease; parkinson*s disease; psychological disorders
03/30/1999US5888535 Antiulcer agents, reduced side effects
03/30/1999US5888534 Controlled release of drugs delivered by sublingual or buccal administration
03/30/1999US5888531 Freeze-dried preparation for pharmaceutical use
03/30/1999US5888523 Topical non-steroidal anti-inflammatory drug composition
03/30/1999US5888520 Composition, barrier film, and method for preventing contact dermatitis
03/30/1999US5888518 Method for preventing and treating coccidiosis
03/30/1999US5888515 Rhus dermatitis treatment composition and method
03/30/1999US5888506 A detergent free polypeptide in the form of crystal structure or lyophilized or conjugated with polyoxyethylene glycol and contains less than 1 ng endotoxin per mg protein
03/30/1999US5888494 Topical
03/30/1999US5888492 Mixture of hydrocarbon oil, flow control agent and fatty ester
03/30/1999US5888484 Composition for bleaching hair
03/30/1999CA2249049A1 Chromene derivatives and salts thereof, and pharmaceuticals containing the same
03/30/1999CA2170608C 5-(1-fluoro-vinyl)-1h-pyrimidine-2,4-dione derivatives useful as antineoplastic agents
03/30/1999CA2168731C Antiparasitic agents
03/30/1999CA2099670C Flavor stable zinc acetate compositions for oral absorption
03/30/1999CA2093133C Synthetic lung surfactant
03/30/1999CA2085975C Dentinal desensitizing compositions
03/30/1999CA2053903C Heterocyclic n-oxide derivatives of substituted benzo¬5,6|cycloheptapyridines, compositions and methods of use
03/30/1999CA2047216C 9-substituted-8-unsubstituted-9-deazaguanines
03/30/1999CA1340475C Dopamine analog amide
03/26/1999CA2249074A1 Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014239A1 Composition for treating diabetes mellitus and obesity
1 ... 6521 6522 6523 6524 6525 6526 6527 6528 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 ... 7860